Hemideina
PrivateLast Round
Series A
Oct 20, 2021
Total Funding Raised
$10.86M
Company Overview
Hemideina is a medical technology company that develops cochlear implant solutions for the treatment of severe-to-profound hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemideina Comparables
Compare Hemideina with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neubio | 81% | |
| MED-EL | 79% | |
| Envoy Medical, Inc. | 78% | |
Hemideina Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 20, 2021 | ||||
| Series A Extension | Nov 22, 2019 | ||||
| Series A | Feb 20, 2019 |
Hemideina Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Geoni Capital | Series A |
| Escala Partners | Series A |
| InterValley Ventures | Series A |
| Henslow | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 22, 2019
$3M round led by Henslow
- Feb 20, 2019
$715K round led by Chatsworth Associates.
Hemideina Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hemideina's valuation, stock price, and market status.